Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism

Cytokine and Growth Factor Reviews

Volumn 22, Issue 5-6, 2011, Pages 331-338

  Bondue, Benjamin ^a   Wittamer, Valérie ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Adipokine; CCRL2; Chemerin; Chemotaxis; ChemR23; CMKLR1; CRAM; GPR1; HCR; Tig2

Indexed keywords

ADIPOCYTOKINE; BLT1 PROTEIN; CATHELICIDIN; CHEMERIN; CHEMOTACTIC FACTOR; CHEMR23 RECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 30; GLUCOSE; INTERFERON; KININOGEN; LEUKOTRIENE B4 RECEPTOR; LIGAND; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROCHEMERIN; PROTEIN PRECURSOR; RESOLVIN E1; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADIPOCYTE; ALLERGIC ENCEPHALOMYELITIS; AMINO TERMINAL SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL INFILTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INFLAMMATION; INTERFERON PRODUCTION; INTERNALIZATION; KERATINOCYTE; LEUKOCYTE; LEUKOCYTIC INFILTRATION; LIPOLYSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MACROPHAGE; MESENCHYMAL STEM CELL; METABOLISM; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OBESITY; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PSORIASIS; SKIN LUPUS ERYTHEMATOSUS; VIRUS PNEUMONIA;

AMINO ACID SEQUENCE; ANIMALS; CHEMOKINES; CHEMOTAXIS, LEUKOCYTE; INFLAMMATION; OLIGOPEPTIDES; RECEPTORS, CHEMOKINE;

ANIMALIA;

EID: 82955203470     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2011.11.004     Document Type: Article

References (60)

1. Gantz I., Konda Y., Yang Y.K., Miller D.E., Dierick H.A., Yamada T. Molecular cloning of a novel receptor (CMKLR1) with homology to the chemotactic factor receptors. Cytogenet Cell Genet 1996, 74:286-290.
2. Samson M., Edinger A.L., Stordeur P., Rucker J., Verhasselt V., Sharron M., et al. ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains. Eur J Immunol 1998, 28:1689-1700.
3. Wittamer V., Franssen J.D., Vulcano M., Mirjolet J.F., Le Poul E., Migeotte I., et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003, 198:977-985.
4. Nagpal S., Patel S., Jacobe H., DiSepio D., Ghosn C., Malhotra M., et al. Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol 1997, 109:91-95.
5. Allen S.J., Zabel B.A., Kirkpatrick J., Butcher E.C., Nietlispach D., Handel T.M. NMR assignment of human chemerin, a novel chemoattractant. Biomol NMR Assign 2007, 1:171-173.
6. Mortier A., Gouwy M., Van Damme J., Proost P. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines. Exp Cell Res 2011, 317:642-654.
7. Wittamer V., Gregoire F., Robberecht P., Vassart G., Communi D., Parmentier M. The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency. J Biol Chem 2004, 279:9956-9962.
8. Luangsay S., Wittamer V., Bondue B., De Henau O., Rouger L., Brait M., et al. Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. J Immunol 2009, 183:6489-6499.
9. Kulig P., Kantyka T., Zabel B.A., Banas M., Chyra A., Stefanska A., et al. Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins. J Immunol 2011, 187:1403-1410.
10. Shimamura K., Matsuda M., Miyamoto Y., Yoshimoto R., Seo T., Tokita S. Identification of a stable chemerin analog with potent activity toward ChemR23. Peptides 2009, 30:1529-1538.
11. Cash J.L., Hart R., Russ A., Dixon J.P., Colledge W.H., Doran J., et al. Synthetic chemerin-derived peptides suppress inflammation through ChemR23. J Exp Med 2008, 205:767-775.
12. Yamaguchi Y., Du X.Y., Zhao L., Morser J., Leung L.L. Proteolytic cleavage of chemerin is necessary for activation to the active form, chem157S, which functions as a signaling molecule in glioblastoma. J Biol Chem 2011, [Epub ahead of print].
13. Wittamer V., Bondue B., Guillabert A., Vassart G., Parmentier M., Communi D. Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity. J Immunol 2005, 175:487-493.
14. Zabel B.A., Allen S.J., Kulig P., Allen J.A., Cichy J., Handel T.M., et al. Chemerin activation by serine proteases of the coagulation fibrinolytic and inflammatory cascades. J Biol Chem 2005, 280:34661-34666.
15. Du X.Y., Zabel B.A., Myles T., Allen S.J., Handel T.M., Lee P.P., et al. Regulation of chemerin bioactivity by plasma carboxypeptidase N, carboxypeptidase B (activated thrombin-activable fibrinolysis inhibitor), and platelets. J Biol Chem 2009, 284:751-758.
16. Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al. Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin. J Immunol 2007, 178:3713-3720.
17. Guillabert A., Wittamer V., Bondue B., Godot V., Imbault V., Parmentier M., et al. Role of neutrophil proteinase 3 and mast cell chymase in chemerin proteolytic regulation. J Leukoc Biol 2008, 84:1530-1538.
18. Zhao L., Yamaguchi Y., Sharif S., Du X.Y., Lee D.M., Recht L.D., et al. Chemerin 158K is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J Biol Chem 2011, [Epub ahead of print].
19. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J Exp Med 2005, 201:509-515.
20. Berg V., Sveinbjornsson B., Bendiksen S., Brox J., Meknas K., Figenschau Y. Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin(21-157). Arthritis Res Ther 2010, 12:R228.
21. Ernst M.C., Sinal C.J. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010, 21:660-667.
22. Muruganandan S., Parlee S.D., Rourke J.L., Ernst M.C., Goralski K.B., Sinal C.J. Chemerin, a novel peroxisome proliferator-activated receptor γ (PPAR γ) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 2011, 286:23982-23995.
23. Graham K.L., Zabel B.A., Loghavi S., Zuniga L.A., Ho P.P., Sobel R.A., et al. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J Immunol 2009, 183:6717-6723.
24. Parolini S., Santoro A., Marcenaro E., Luini W., Massardi L., Facchetti F., et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007, 109:3625-3632.
25. Zabel B.A., Silverio A.M., Butcher E.C. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J Immunol 2005, 174:244-251.
26. Zabel B.A., Ohyama T., Zuniga L., Kim J.Y., Johnston B., Allen S.J., et al. Chemokine-like receptor 1 expression by macrophages in vivo: regulation by TGF-beta and TLR ligands. Exp Hematol 2006, 34:1106-1114.
27. Sell H., Laurencikiene J., Taube A., Eckardt K., Cramer A., Horrighs A., et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009, 58:2731-2740.
28. Kaur J., Adya R., Tan B.K., Chen J., Randeva H.S. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010, 391:1762-1768.
29. Arita M., Bianchini F., Aliberti J., Sher A., Chiang N., Hong S., et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005, 201:713-722.
30. Arita M., Ohira T., Sun Y.P., Elangovan S., Chiang N., Serhan C.N. Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J Immunol 2007, 178:3912-3917.
31. Barnea G., Strapps W., Herrada G., Berman Y., Ong J., Kloss B., et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008, 105:64-69.
32. Zabel B.A., Nakae S., Zuniga L., Kim J.Y., Ohyama T., Alt C., et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008, 205:2207-2220.
33. Migeotte I., Franssen J.D., Goriely S., Willems F., Parmentier M. Distribution and regulation of expression of the putative human chemokine receptor HCR in leukocyte populations. Eur J Immunol 2002, 32:494-501.
34. Yoshimura T., Oppenheim J.J. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); Two multifunctional receptors with unusual properties. Exp Cell Res 2011, 317:674-684.
35. Otero K., Vecchi A., Hirsch E., Kearley J., Vermi W., Del P.A., et al. Nonredundant role of CCRL2 in lung dendritic cell trafficking. Blood 2010, 116:2942-2949.
36. Biber K., Zuurman M.W., Homan H., Boddeke H.W. Expression of L-CCR in HEK 293 cells reveals functional responses to CCL2, CCL5, CCL7, and CCL8. J Leukoc Biol 2003, 74:243-251.
37. Leick M., Catusse J., Follo M., Nibbs R.J., Hartmann T.N., Veelken H., et al. CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology 2010, 129:536-546.
38. Hart R., Greaves D.R. Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5. J Immunol 2010, 185:3728-3739.
39. Weigert J., Obermeier F., Neumeier M., Wanninger J., Filarsky M., Bauer S., et al. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010, 16:630-637.
40. De Palma G., Castellano G., Del Prete A., Sozzani S., Fiore N., Loverre A., et al. The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis. Kidney Int 2011, 79:1228-1235.
41. Albanesi C., Scarponi C., Pallotta S., Daniele R., Bosisio D., Madonna S., et al. Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 2009, 206:249-258.
42. Nakajima H., Nakajima K., Nagano Y., Yamamoto M., Tarutani M., Takahashi M., et al. Circulating level of chemerin is upregulated in psoriasis. J Dermatol Sci 2010, 60:45-47.
43. Lande R., Gafa V., Serafini B., Giacomini E., Visconti A., Remoli M.E., et al. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J Neuropathol Exp Neurol 2008, 67:388-401.
44. Demoor T., Bracke K.R., Dupont L.L., Plantinga M., Bondue B., Roy M.O., et al. The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation. J Immunol 2011, 186:5457-5467.
45. Cash J.L., Christian A.R., Greaves D.R. Chemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent manner. J Immunol 2010, 184:5315-5324.
46. Bondue B., Vosters O., De Nadai P., Glineur S., De Henau O., Luangsay S., et al. ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia1. PLOS Pathogens 2011, 7:e1002358.
47. Goralski K.B., McCarthy T.C., Hanniman E.A., Zabel B.A., Butcher E.C., Parlee S.D., et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007, 282:28175-28188.
48. Bozaoglu K., Bolton K., McMillan J., Zimmet P., Jowett J., Collier G., et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007, 148:4687-4694.
49. Roh S.G., Song S.H., Choi K.C., Katoh K., Wittamer V., Parmentier M., et al. Chemerin-a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007, 362:1013-1018.
50. Parlee S.D., Ernst M.C., Muruganandan S., Sinal C.J., Goralski K.B. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-{alpha}. Endocrinology 2010, 151:2590-2602.
51. Kralisch S., Weise S., Sommer G., Lipfert J., Lossner U., Bluher M., et al. Interleukin-1ss induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 2009, 154(April):102-106.
52. Bauer S., Wanninger J., Schmidhofer S., Weigert J., Neumeier M., Dorn C., et al. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 2011, 152:26-35.
53. Takahashi M., Takahashi Y., Takahashi K., Zolotaryov F.N., Hong K.S., Kitazawa R., et al. Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008, 582:573-578.
54. Tan B.K., Chen J., Farhatullah S., Adya R., Kaur J., Heutling D., et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009, 58:1971-1977.
55. Ernst M.C., Issa M., Goralski K.B., Sinal C.J. Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 2010, 151:1998-2007.
56. Weigert J., Neumeier M., Wanninger J., Filarsky M., Bauer S., Wiest R., et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010, 72:342-348.
57. Yilmaz Y., Yonal O., Kurt R., Alahdab Y.O., Eren F., Ozdogan O., et al. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand J Gastroenterol 2011, 46:91-97.
58. Spiroglou S.G., Kostopoulos C.G., Varakis J.N., Papadaki H.H. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 2010, 17:115-130.
59. Edinger A.L., Hoffman T.L., Sharron M., Lee B., O'Dowd B., Doms R.W. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins. Virology 1998, 249:367-378.
60. Tokizawa S., Shimizu N., Hui-Yu L., Deyu F., Haraguchi Y., Oite T., et al. Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor. Kidney Int 2000, 58:607-617.